Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Orphanet J Rare Dis ; 7: 70, 2012 Sep 22.
Article in English | MEDLINE | ID: mdl-22998683

ABSTRACT

BACKGROUND: Arteriosclerosis and emphysema develop in individuals with Schimke immuno-osseous dysplasia (SIOD), a multisystem disorder caused by biallelic mutations in SMARCAL1 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1). However, the mechanism by which the vascular and pulmonary disease arises in SIOD remains unknown. METHODS: We reviewed the records of 65 patients with SMARCAL1 mutations. Molecular and immunohistochemical analyses were conducted on autopsy tissue from 4 SIOD patients. RESULTS: Thirty-two of 63 patients had signs of arteriosclerosis and 3 of 51 had signs of emphysema. The arteriosclerosis was characterized by intimal and medial hyperplasia, smooth muscle cell hyperplasia and fragmented and disorganized elastin fibers, and the pulmonary disease was characterized by panlobular enlargement of air spaces. Consistent with a cell autonomous disorder, SMARCAL1 was expressed in arterial and lung tissue, and both the aorta and lung of SIOD patients had reduced expression of elastin and alterations in the expression of regulators of elastin gene expression. CONCLUSIONS: This first comprehensive study of the vascular and pulmonary complications of SIOD shows that these commonly cause morbidity and mortality and might arise from impaired elastogenesis. Additionally, the effect of SMARCAL1 deficiency on elastin expression provides a model for understanding other features of SIOD.


Subject(s)
Arteriosclerosis/physiopathology , Emphysema/physiopathology , Immunologic Deficiency Syndromes/physiopathology , Nephrotic Syndrome/physiopathology , Osteochondrodysplasias/physiopathology , Pulmonary Embolism/physiopathology , Adult , Arteriosclerosis/genetics , Autopsy , Child , Child, Preschool , DNA Helicases/genetics , Emphysema/genetics , Female , Humans , Immunohistochemistry , Immunologic Deficiency Syndromes/genetics , Male , Nephrotic Syndrome/genetics , Osteochondrodysplasias/genetics , Primary Immunodeficiency Diseases , Pulmonary Embolism/genetics
2.
Eur J Pediatr ; 169(7): 801-11, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20013129

ABSTRACT

Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by prominent spondyloepiphyseal dysplasia, T cell deficiency, and focal segmental glomerulosclerosis. Biallelic mutations in swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) are the only identified cause of SIOD, but approximately half of patients referred for molecular studies do not have detectable mutations in SMARCAL1. We hypothesized that skeletal features distinguish between those with or without SMARCAL1 mutations. Therefore, we analyzed the skeletal radiographs of 22 patients with and 11 without detectable SMARCAL1 mutations. We found that patients with SMARCAL1 mutations have a spondyloepiphyseal dysplasia (SED) essentially limited to the spine, pelvis, capital femoral epiphyses, and possibly the sella turcica, whereas the hands and other long bones are basically normal. Additionally, we found that several of the adolescent and young adult patients developed osteoporosis and coxarthrosis. Of the 11 patients without detectable SMARCAL1 mutations, seven had a SED indistinguishable from patients with SMARCAL1 mutations. We conclude therefore that SED is a feature of patients with SMARCAL1 mutations and that skeletal features do not distinguish who of those with SED have SMARCAL1 mutations.


Subject(s)
Bone and Bones/diagnostic imaging , DNA Helicases/genetics , Mutation , Osteochondrodysplasias/diagnostic imaging , Osteochondrodysplasias/genetics , Adolescent , Adult , Child , Child, Preschool , Diagnosis, Differential , Genetic Heterogeneity , Glomerulosclerosis, Focal Segmental/genetics , Humans , Lymphopenia/genetics , Phenotype , Radiography , Syndrome
3.
Hum Mutat ; 28(3): 273-83, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17089404

ABSTRACT

Schimke immunoosseous dysplasia (SIOD), which is characterized by prominent spondyloepiphyseal dysplasia, T-cell deficiency, and focal segmental glomerulosclerosis, is a panethnic autosomal recessive multisystem disorder with variable expressivity. Biallelic mutations in switch/sucrose nonfermenting (swi/snf) related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) are the only identified cause of SIOD. However, among 72 patients from different families, we identified only 38 patients with biallelic mutations in the coding exons and splice junctions of the SMARCAL1 gene. This observation, the variable expressivity, and poor genotype-phenotype correlation led us to test several hypotheses including modifying haplotypes, oligogenic inheritance, or locus heterogeneity in SIOD. Haplotypes associated with the two more common mutations, R820H and E848X, did not correlate with phenotype. Also, contrary to monoallelic SMARCAL1 coding mutations indicating oligogenic inheritance, we found that all these patients did not express RNA and/or protein from the other allele and thus have biallelic SMARCAL1 mutations. We hypothesize therefore that the variable expressivity among patients with biallelic SMARCAL1 mutations arises from environmental, genetic, or epigenetic modifiers. Among patients without detectable SMARCAL1 coding mutations, our analyses of cell lines from four of these patients showed that they expressed normal levels of SMARCAL1 mRNA and protein. This is the first evidence for nonallelic heterogeneity in SIOD. From analysis of the postmortem histopathology from two patients and the clinical data from most patients, we propose the existence of endophenotypes of SIOD.


Subject(s)
Genetic Variation , Immunologic Deficiency Syndromes/genetics , Osteochondrodysplasias/genetics , Algorithms , Child , Child, Preschool , DNA Helicases/genetics , DNA Mutational Analysis , Female , Genetic Testing , Humans , Infant , Infant, Newborn , Male , Phenotype
4.
Am J Med Genet A ; 135(2): 206-10, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15884045

ABSTRACT

Schimke immuno-osseous dysplasia (SIOD) is characterized by spondyloepiphyseal dysplasia, nephropathy, and T-cell deficiency. SIOD is caused by mutations in the putative chromatin remodeling protein SMARCAL1. We report an 8-year-old boy with SIOD and recurrent, severe, refractory migraine-like headaches. Through a retrospective questionnaire-based study, we found that refractory and severely disabling migraine-like headaches occur in nearly half of SIOD patients. We have also found that the vasodilator minoxidil provided symptomatic relief for one patient. We hypothesize that these headaches may arise from an intrinsic vascular, neuroimmune, or neurovascular defect resulting from loss of SMARCAL1 function.


Subject(s)
Bone Diseases, Developmental/complications , Headache/complications , Bone Diseases, Developmental/metabolism , Bone Diseases, Developmental/pathology , Child , DNA Helicases/analysis , DNA Helicases/genetics , Headache/pathology , Humans , Immune System Diseases/pathology , Immunohistochemistry , Male , Migraine Disorders/complications , Migraine Disorders/pathology , Mutation , Retrospective Studies , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...